|
DE1118403B
(de)
|
1960-01-27 |
1961-11-30 |
Hoechst Ag |
Verfahren zur Gewinnung von antitumorwirksamen Sporen
|
|
FR1275M
(fr)
|
1961-05-06 |
1962-05-02 |
Rene Roger |
Médicament a base de colibacilles vivants.
|
|
NL294835A
(https=)
|
1962-07-19 |
1900-01-01 |
|
|
|
FR2828M
(fr)
|
1963-03-01 |
1964-11-02 |
Lucien Nouvel |
Médicament renfermant des colibacilles antibiorésistants.
|
|
FR5528M
(https=)
|
1965-10-01 |
1967-11-13 |
|
|
|
GB1271674A
(en)
|
1968-07-09 |
1972-04-26 |
Nisshin Flour Milling Co |
Process and preparation for treating diarrhoea in pigs
|
|
SE371209B
(https=)
|
1969-10-13 |
1974-11-11 |
Cernelle Ab |
|
|
DE2134179A1
(de)
|
1971-07-09 |
1973-01-25 |
Rolf Dr Schuler |
Bifidobakterien enthaltendes praeparat und verfahren zur herstellung desselben
|
|
FR2244464A1
(en)
|
1973-06-26 |
1975-04-18 |
Serozym Laboratoires |
Yeast, lacto- and colibacillus based compsns - used to modify intestinal flora, treat colitis and digestive disorders, etc.
|
|
US4098728A
(en)
|
1976-01-02 |
1978-07-04 |
Solomon Rosenblatt |
Medical surgical sponge and method of making same
|
|
AU510985B2
(en)
|
1977-03-29 |
1980-07-24 |
Capsugel A.G. |
Liquid filled capsule
|
|
DE2722806C2
(de)
|
1977-05-20 |
1984-12-13 |
Capsugel AG, Basel |
Kapselkörper für eine Steckkapsel für Arzneimittel oder andere portionsweise zu verpackende Stoffe, sowie Verfahren zu seiner Herstellung
|
|
DE2722807A1
(de)
|
1977-05-20 |
1978-11-23 |
Capsugel Ag |
Verfahren zum herstellen einer mit viskosem stoff gefuellten steckkapsel
|
|
DE2722822C2
(de)
|
1977-05-20 |
1984-11-08 |
Capsugel AG, Basel |
Verfahren zum Herstellen einer zum Aufnehmen eines viskosen Stoffes, insbesondere eines flüssigen Arzneimittels, geeigneten Steckkapsel
|
|
US4335107A
(en)
|
1978-06-05 |
1982-06-15 |
Snoeyenbos Glenn H |
Mixture to protect poultry from salmonella
|
|
CH642990A5
(de)
|
1978-07-24 |
1984-05-15 |
Parke Davis & Co |
Verfahren zum faerben von gelatine fuer kapseln mit hilfe eines gegen den abbau durch licht oder oxidation stabilisierten natuerlichen farbstoffes.
|
|
CH637297A5
(fr)
|
1978-12-05 |
1983-07-29 |
Nestle Sa |
Microbille comprenant un microorganisme et son procede de fabrication.
|
|
US4309782A
(en)
|
1980-09-11 |
1982-01-12 |
Esteban Paulin |
Device for collecting fecal specimens
|
|
US4536409A
(en)
|
1981-01-23 |
1985-08-20 |
American Can Company |
Oxygen scavenger
|
|
US4394377A
(en)
|
1981-07-31 |
1983-07-19 |
Syntex (U.S.A.) Inc. |
Ruminant animal performance by co-administering choline and propionate enchancers
|
|
US4452779A
(en)
|
1982-02-03 |
1984-06-05 |
Cockerill Vernon |
Composition and method of treating lactating mammals
|
|
US4537776A
(en)
|
1983-06-21 |
1985-08-27 |
The Procter & Gamble Company |
Penetrating topical pharmaceutical compositions containing N-(2-hydroxyethyl) pyrrolidone
|
|
FI840816A0
(fi)
|
1984-03-01 |
1984-03-01 |
Farmos Oy |
Bakteriepreparat
|
|
JPS615022A
(ja)
|
1984-06-19 |
1986-01-10 |
Advance Res & Dev Co Ltd |
腸内細菌叢改善剤
|
|
US4892731A
(en)
|
1986-12-11 |
1990-01-09 |
Tadashi Arai |
Biological intestinal antiseptics
|
|
IL86859A
(en)
|
1987-07-10 |
1991-12-15 |
E Z Em Inc |
Aqueous cathartic solution containing inorganic salts
|
|
US4948734A
(en)
|
1987-08-12 |
1990-08-14 |
Mycogen Corporation |
Novel isolates of bacillus thuringiensis having activity against nematodes
|
|
EP0303246A3
(en)
|
1987-08-12 |
1990-06-20 |
The B.F. Goodrich Company |
Hydrogenated, ring-opened polymers of cycloolefins
|
|
DE68928665T2
(de)
|
1988-08-02 |
1998-11-12 |
Gastro Services Pty Ltd |
Behandlung von gastro-intestinalen krankheiten
|
|
US5443826A
(en)
|
1988-08-02 |
1995-08-22 |
Borody; Thomas J. |
Treatment of gastro-intestinal disorders with a fecal composition or a composition of bacteroides and E. Coli
|
|
US5213807A
(en)
|
1990-05-03 |
1993-05-25 |
Chemburkar Pramod B |
Pharmaceutical composition containing ibuprofen and a prostaglandin
|
|
JP2961184B2
(ja)
|
1990-05-07 |
1999-10-12 |
ミヤリサン株式会社 |
クロストリジウム・ディフィシル下痢症および偽膜性大腸炎の予防ならびに治療用医薬組成物
|
|
US5266315A
(en)
|
1990-05-07 |
1993-11-30 |
Kabushiki Kaisha Miyarisan Seibutsu Igaku Kenkyusho |
Composite for Clostridium difficile diarrhea and pseudomembranous colitis
|
|
GB9107305D0
(en)
|
1991-04-08 |
1991-05-22 |
Unilever Plc |
Probiotic
|
|
JP3047143B2
(ja)
|
1992-04-24 |
2000-05-29 |
堀井薬品工業株式会社 |
腸管洗浄液用組成物及び腸管洗浄液
|
|
US5317849A
(en)
|
1992-08-07 |
1994-06-07 |
Sauter Manufacturing Corporation |
Encapsulation equipment and method
|
|
JP3850891B2
(ja)
|
1994-03-01 |
2006-11-29 |
ゼリア新薬工業株式会社 |
緩下効果を有する組成物
|
|
US6984513B2
(en)
|
1994-03-03 |
2006-01-10 |
The Board Of Trustees Of The Leland Stanford Junior University |
Anaerobe targeted enzyme-mediated prodrug therapy
|
|
JPH07242557A
(ja)
|
1994-03-03 |
1995-09-19 |
Ss Pharmaceut Co Ltd |
乳酸菌含有瀉下薬組成物
|
|
NZ287420A
(en)
|
1994-05-26 |
1997-12-19 |
Bracco Spa |
Lactobacillus strains with enhanced gut adhesion
|
|
US5599795A
(en)
|
1994-08-19 |
1997-02-04 |
Mccann; Michael |
Method for treatment of idiopathic inflammatory bowel disease (IIBD)
|
|
AUPM864894A0
(en)
|
1994-10-07 |
1994-11-03 |
Borody, Thomas Julius |
Treatment of bowel-dependent neurological disorders
|
|
US5800821A
(en)
|
1995-03-10 |
1998-09-01 |
New England Medical Center Hospitals, Inc. |
Bacterial spores as a heat stable vaccine delivery system
|
|
US7048906B2
(en)
|
1995-05-17 |
2006-05-23 |
Cedars-Sinai Medical Center |
Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
|
|
US5858356A
(en)
|
1995-12-21 |
1999-01-12 |
Abbott Laboratories |
Lactobacillus acidophilus to inhibit cryptosporidiosis in mammals
|
|
US5902578A
(en)
|
1996-03-25 |
1999-05-11 |
Abbott Laboratories |
Method and formula for the prevention of diarrhea
|
|
US5837238A
(en)
|
1996-06-05 |
1998-11-17 |
Biogaia Biologics Ab |
Treatment of diarrhea
|
|
US6087386A
(en)
|
1996-06-24 |
2000-07-11 |
Merck & Co., Inc. |
Composition of enalapril and losartan
|
|
WO1998013068A1
(fr)
|
1996-09-26 |
1998-04-02 |
Vladimir Borisovich Kuperman |
Medicament prophylactique 'trisan'
|
|
US5948787A
(en)
|
1997-02-28 |
1999-09-07 |
Alza Corporation |
Compositions containing opiate analgesics
|
|
US6162464A
(en)
|
1997-03-31 |
2000-12-19 |
Inkine Pharmaceutical, Inc. |
Non-aqueous colonic purgative formulations
|
|
US7374753B1
(en)
|
1997-06-03 |
2008-05-20 |
Ganeden Biotech, Inc. |
Probiotic lactic acid bacterium to treat bacterial infections associated with SIDS
|
|
US6428783B1
(en)
|
1998-03-11 |
2002-08-06 |
Medtech Center, Inc. |
Bank of autochthonous strains of microorganisms and methods of its use for recovery of intestinal microbiocenosis of the men
|
|
US5902743A
(en)
|
1998-03-20 |
1999-05-11 |
Wisconsin Alumni Research Foundation |
Probiotic bifidobacterium strain
|
|
CN1300318A
(zh)
|
1998-05-06 |
2001-06-20 |
中村启次郎 |
含有性质不同且彼此共生的微生物和其代谢物的微生物培养物,含有该培养物活性组分的载体和吸附剂及其用途
|
|
US6368591B2
(en)
|
1998-05-15 |
2002-04-09 |
Shanghai Sine Pharmaceutical Corporation Ltd. |
Beneficial microbe composition, new protective materials for the microbes, method to prepare the same and uses thereof
|
|
FR2779962B1
(fr)
|
1998-06-17 |
2002-12-06 |
Karim Ioualalen |
Composition cosmetique ou dermopharmaceutique sous forme de perles et procedes pour la preparation
|
|
AT407008B
(de)
|
1998-08-06 |
2000-11-27 |
Viernstein Helmut Dr |
Formulierungen mit probiotisch wirksamen mikroorganismen
|
|
US6461607B1
(en)
|
1998-08-24 |
2002-10-08 |
Ganeden Biotech, Inc. |
Probiotic, lactic acid-producing bacteria and uses thereof
|
|
AU6049599A
(en)
|
1998-09-17 |
2000-04-03 |
Baxter Healthcare Sa |
Streptococcal c beta protein compositions
|
|
EP1005863A1
(en)
|
1998-12-04 |
2000-06-07 |
Synthelabo |
Controlled-release dosage forms comprising a short acting hypnotic or a salt thereof
|
|
WO2000035465A2
(en)
|
1998-12-11 |
2000-06-22 |
Urex Biotech Inc. |
Oral administration of lactobacillus for the treatment and prevention of urogenital infection
|
|
US6245740B1
(en)
|
1998-12-23 |
2001-06-12 |
Amgen Inc. |
Polyol:oil suspensions for the sustained release of proteins
|
|
ID29150A
(id)
|
1999-01-15 |
2001-08-02 |
Entpr Ireland Cs |
Penggunaan lactobacillus salivarius
|
|
US7763276B1
(en)
|
1999-02-26 |
2010-07-27 |
Shionogi & Co., Ltd. |
Chewable soft capsules having improved administration properties and process for producing the same
|
|
EP1204410B1
(en)
|
1999-07-30 |
2012-09-12 |
Capsugel Belgium NV |
Multi-component pharmaceutical dosage form
|
|
FR2808689B1
(fr)
|
2000-05-11 |
2004-09-03 |
Agronomique Inst Nat Rech |
Utilisation de souches acetogenes hydrogenotrophes pour la prevention ou le traitement de troubles digestifs
|
|
US20040170617A1
(en)
|
2000-06-05 |
2004-09-02 |
Finegold Sydney M. |
Method of treating diseases associated with abnormal gastrointestinal flora
|
|
US20020013270A1
(en)
|
2000-06-05 |
2002-01-31 |
Bolte Ellen R. |
Method for treating a mental disorder
|
|
US20040062757A1
(en)
|
2001-06-05 |
2004-04-01 |
Finegold Sydney M. |
Method of testing gastrointestinal diseases associated with species of genus clostridium
|
|
US6756032B1
(en)
|
2000-07-12 |
2004-06-29 |
The Procter & Gamble Company |
Method to enhance and/or prolong the effects of a primary challenge to a responsive system with a secondary challenge
|
|
EP1303285A2
(en)
|
2000-07-17 |
2003-04-23 |
Chr. Hansen A/S |
Methods and formulations with probiotic microorganisms and medicaments
|
|
AUPQ899700A0
(en)
|
2000-07-25 |
2000-08-17 |
Borody, Thomas Julius |
Probiotic recolonisation therapy
|
|
US7214370B2
(en)
|
2000-12-18 |
2007-05-08 |
Probiohealth, Llc |
Prebiotic and preservative uses of oil-emulsified probiotic encapsulations
|
|
US6790453B2
(en)
|
2001-03-14 |
2004-09-14 |
Mccormick & Company, Inc. |
Encapsulation compositions and process for preparing the same
|
|
US7815956B2
(en)
|
2001-04-27 |
2010-10-19 |
Pepsico |
Use of erythritol and D-tagatose in diet or reduced-calorie beverages and food products
|
|
AU2002305758B2
(en)
|
2001-06-01 |
2006-09-07 |
Nuvo Pharmaceuticals (Ireland) Designated Activity Company |
Pharmaceutical compositions for the coordinated delivery of NSAIDs
|
|
US20030092163A1
(en)
|
2001-07-26 |
2003-05-15 |
Collins John Kevin |
Probiotic bifidobacterium strains
|
|
US20030092724A1
(en)
|
2001-09-18 |
2003-05-15 |
Huaihung Kao |
Combination sustained release-immediate release oral dosage forms with an opioid analgesic and a non-opioid analgesic
|
|
GB0122935D0
(en)
|
2001-09-24 |
2001-11-14 |
Meridica Ltd |
Dispensing small quantities of particles
|
|
GB0124580D0
(en)
|
2001-10-12 |
2001-12-05 |
Univ Reading |
New composition
|
|
EP1492505B1
(en)
|
2002-04-05 |
2015-06-03 |
Euro-Celtique S.A. |
Pharmaceutical preparation containing oxycodone and naloxone
|
|
CA2391422A1
(en)
|
2002-07-12 |
2004-01-12 |
David William Molloy |
Rifampin (rifadin, rimactone, rifampicin) and doxycycline, (doryx, vibramycin) and the tetracyclines and other compounds currently classified as antibiotics and anti-tuberculous drugs as a treatment to prevent, modify disease progression and/or improve symptoms for neurodegenerative diseases including alzheimers disease, lewy body dementia, schizophrenia,...
|
|
EP1396263A1
(en)
|
2002-08-09 |
2004-03-10 |
Warner-Lambert Company |
Film coating for tablets and caplets
|
|
IL152127A0
(en)
|
2002-10-06 |
2003-05-29 |
Bio Balance Corp |
Probiotic compositions for the treatment of inflammatory bowel disease
|
|
FR2852843B1
(fr)
|
2003-03-24 |
2008-05-23 |
Karim Ioualalen |
Systeme galenique permettant le masquage du gout
|
|
KR20060073937A
(ko)
|
2003-08-18 |
2006-06-29 |
더 바이오 밸런스 코포레이션 |
안정한 액상 촉생제 조성물, 그의 제조 및 응용
|
|
US8192733B2
(en)
|
2003-08-29 |
2012-06-05 |
Cobb & Associates |
Probiotic composition useful for dietary augmentation and/or combating disease states and adverse physiological conditions
|
|
US7749509B2
(en)
|
2003-08-29 |
2010-07-06 |
Cobb And Company, Llp |
Treatment of autism using probiotic composition
|
|
US20060177424A1
(en)
|
2003-08-29 |
2006-08-10 |
Cobb Mark L |
Treatment of disease states and adverse physiological conditions utilizing anti-fungal compositions
|
|
US7759105B2
(en)
|
2003-08-29 |
2010-07-20 |
Cobb & Company, Llp |
Probiotic composition useful for dietary augmentation and/or combating disease states and adverse physiological conditions
|
|
US8016816B2
(en)
|
2003-09-09 |
2011-09-13 |
Convatec Technologies Inc. |
Fecal management appliance and method and apparatus for introducing same
|
|
US7541091B2
(en)
|
2004-05-18 |
2009-06-02 |
M & G Usa Corporation |
Compartmentalized resin pellets for oxygen scavenging
|
|
GB0414811D0
(en)
|
2004-07-01 |
2004-08-04 |
Meridica Ltd |
Dispensing small quantities of particles
|
|
JP2006018748A
(ja)
|
2004-07-05 |
2006-01-19 |
Canon Inc |
情報処理装置及びその制御方法、並びにコンピュータプログラム及びコンピュータ可読記憶媒体
|
|
WO2006013588A1
(en)
|
2004-08-05 |
2006-02-09 |
Anidral S.R.L. |
Folic acid producing bifidobacterium bacterial strains, formulations and use thereof
|
|
ATE367821T1
(de)
|
2004-08-05 |
2007-08-15 |
Anidral Srl |
Folsäure produzierende bifidobacterium bakterienstämme, ihre formulierungen und verwendung
|
|
US20070254314A1
(en)
|
2004-09-16 |
2007-11-01 |
Geier Mark R |
Methods of treating autism and autism spectrum disorders
|
|
EP1802287A2
(en)
|
2004-09-27 |
2007-07-04 |
Sigmoid Biotechnologies Limited |
Minicapsule formulations
|
|
US20060076536A1
(en)
|
2004-09-29 |
2006-04-13 |
Barshied Scott R |
Oxygen scavenging pharmaceutical package and methods for making same
|
|
US20060115465A1
(en)
|
2004-10-29 |
2006-06-01 |
Macfarlane George |
Treatment of gastrointestinal disorders
|
|
US7799328B2
(en)
|
2004-12-23 |
2010-09-21 |
Biocodex |
Method for treating weight loss in patients suffering from inflammatory bowel diseases
|
|
WO2006127355A2
(en)
|
2005-05-20 |
2006-11-30 |
Dow Global Technologies Inc. |
Oral drug compliance monitoring using radio frequency identification tags
|
|
US20060275223A1
(en)
|
2005-06-02 |
2006-12-07 |
Burr James B |
Erythritol compositions for teeth and gums
|
|
PL1890732T3
(pl)
|
2005-06-17 |
2018-11-30 |
Wisconsin Alumni Research Foundation |
Preparaty zwężające naczynia krwionośne do podawania miejscowego i sposoby ochrony komórek podczas chemioterapii i radioterapii przeciwnowotworowej
|
|
TWI362949B
(en)
|
2005-09-13 |
2012-05-01 |
Bion Tech Inc |
Intestines dissolving nature is able to bear the hydrochloric acid in gastric juice and wrap up the benefit covered and grow the fungus of makes up
|
|
CA2635313C
(en)
|
2005-12-29 |
2013-12-31 |
Osmotica Corp. |
Triple combination release multi-layered tablet
|
|
GB0607534D0
(en)
|
2006-04-13 |
2006-05-24 |
Univ London Pharmacy |
Colonic drug delivery formulation
|
|
JP5006567B2
(ja)
|
2006-04-14 |
2012-08-22 |
花王株式会社 |
口腔用固形製剤
|
|
US7845475B2
(en)
|
2006-05-19 |
2010-12-07 |
Her Yuan Chyun Co., Ltd. |
Controller for magnetic wheels
|
|
EP1886784A1
(en)
|
2006-08-09 |
2008-02-13 |
Pfizer Products Inc. |
Clamping apparatus and method
|
|
US7998510B2
(en)
|
2006-08-17 |
2011-08-16 |
C. B. Fleet Company, Inc. |
Low dose colonic cleansing system
|
|
JP2008106066A
(ja)
|
2006-09-25 |
2008-05-08 |
Tashiro Yasuaki |
サポニン及び生菌を含有する組成物
|
|
CN101595133B
(zh)
|
2006-10-27 |
2012-11-14 |
比利时胶囊公司 |
羟丙基甲基纤维素硬胶囊及制备方法
|
|
DE102006062250A1
(de)
|
2006-12-22 |
2008-06-26 |
Roland Saur-Brosch |
Verwendung einer Zusammensetzung aus Mineralstoffen und/oder Vitaminen und gegebenenfalls acetogenen und/oder butyrogenen Bakterien zur oralen oder rektalen Verabreichung für die Behandlung und Vorbeugung von abdominalen Beschwerden
|
|
SI2136825T1
(sl)
|
2007-03-01 |
2014-04-30 |
Probi Ab |
Uporaba lactobacillus plantarium za povečanje bakterijske raznolikosti
|
|
EP2134833B1
(en)
|
2007-03-28 |
2016-03-09 |
Alimentary Health Limited |
Probiotic bifidobacterium strain
|
|
BRPI0809448A2
(pt)
|
2007-03-28 |
2014-09-09 |
Alimentary Health Ltd |
Cepas de bifidobacterium probióticas
|
|
ES2393814T3
(es)
|
2007-04-04 |
2012-12-28 |
Sigmoid Pharma Limited |
Una composición farmacéutica oral
|
|
CA2685118C
(en)
|
2007-04-26 |
2016-11-01 |
Sigmoid Pharma Limited |
Manufacture of multiple minicapsules
|
|
DK2152250T3
(da)
|
2007-05-07 |
2019-12-09 |
Evonik Degussa Gmbh |
Faste doseringsformer, der omfatter et enterisk overtræk, med accelereret lægemiddelfrigivelse
|
|
EP2155167A2
(en)
|
2007-06-04 |
2010-02-24 |
Egalet A/S |
Controlled release pharmaceutical compositions for prolonged effect
|
|
JP2010529073A
(ja)
|
2007-06-06 |
2010-08-26 |
ビーエーエスエフ ソシエタス・ヨーロピア |
チュアブル錠及びトローチ剤製造のための医薬製剤
|
|
MX2009013063A
(es)
|
2007-06-06 |
2010-01-15 |
Basf Se |
Formulacion farmaceutica para la produccion de tabletas de desintegracion rapida.
|
|
EP2264042B1
(en)
|
2007-07-27 |
2012-07-18 |
Cargill, Incorporated |
Micronization of polyols
|
|
EP2030623A1
(en)
|
2007-08-17 |
2009-03-04 |
Nestec S.A. |
Preventing and/or treating metabolic disorders by modulating the amount of enterobacteria
|
|
EP2183318B1
(en)
|
2007-08-31 |
2012-03-07 |
Invista Technologies S.A R.L. |
Oxygen scavenging plastic compositions
|
|
US20100233278A1
(en)
|
2007-09-27 |
2010-09-16 |
Akiko Ookawa |
Rapidly disintegrating solid preparation
|
|
EP2205213A2
(en)
|
2007-10-01 |
2010-07-14 |
Laboratorios Lesvi, S.L. |
Orodispersible tablets
|
|
CA2702935A1
(en)
|
2007-10-19 |
2009-04-23 |
Purdue Research Foundation |
Solid formulations of crystalline compounds
|
|
US8658153B2
(en)
|
2007-10-20 |
2014-02-25 |
Universite De Liege |
Bifidobacterial species
|
|
EP2211879B1
(en)
|
2007-10-26 |
2014-05-07 |
Brenda E. Moore |
Probiotic compositions and methods for inducing and supporting weight loss
|
|
JP5258268B2
(ja)
|
2007-11-19 |
2013-08-07 |
フロイント産業株式会社 |
球形粒の製造方法
|
|
US9314454B2
(en)
|
2007-12-28 |
2016-04-19 |
Sawai Pharmaceutical Co., Ltd. |
Oral cavity disintegrating tablet and method of producing the same
|
|
CN101496819A
(zh)
|
2008-01-31 |
2009-08-05 |
青岛东海药业有限公司 |
真杆菌、梭菌制剂及其应用
|
|
KR100913405B1
(ko)
|
2008-03-25 |
2009-08-21 |
광주과학기술원 |
Ｔｈ２－매개 면역 질환의 예방 또는 치료용 조성물
|
|
WO2009149149A1
(en)
|
2008-06-04 |
2009-12-10 |
Trustees Of Dartmouth College |
Prevention or treatment of immune-relevant disease by modification of microfloral populations
|
|
US9603876B2
(en)
|
2008-09-25 |
2017-03-28 |
New York University |
Compositions and methods for restoring gastrointestinal microbiota following antibiotic treatment
|
|
TW201018819A
(en)
|
2008-10-02 |
2010-05-16 |
Pfizer |
Rotary supply joint, rotary timing valve and product handling apparatus
|
|
HRP20200284T1
(hr)
|
2008-10-02 |
2020-07-10 |
Salix Pharmaceuticals, Ltd. |
Postupci liječenja hepatičke encefalopatije
|
|
KR101264510B1
(ko)
|
2008-11-20 |
2013-05-14 |
화이자 인코포레이티드 |
캡슐 취급 장치 및 캡슐 취급 장치를 포함하는 캡슐 처리 장비
|
|
US20100178413A1
(en)
|
2008-12-17 |
2010-07-15 |
Mark Gorris |
Food-based Supplement Delivery System
|
|
WO2010103132A1
(es)
|
2009-03-10 |
2010-09-16 |
Hero España, S.A. |
Aislamiento, identificación y caracterización de cepas con actividad probiótica a partir de heces de lactantes alimentados exclusivamente con leche materna
|
|
US20100255231A1
(en)
|
2009-04-01 |
2010-10-07 |
Multisorb Technologies, Inc. |
Oxygen scavenging films
|
|
CA2760248C
(en)
|
2009-04-30 |
2019-05-28 |
Actogenix Nv |
Cryoprotectants for freeze drying of lactic acid bacteria
|
|
US20100285164A1
(en)
|
2009-05-11 |
2010-11-11 |
Jrs Pharma |
Orally Disintegrating Excipient
|
|
ES2530049T3
(es)
|
2009-05-18 |
2015-02-26 |
Sigmoid Pharma Limited |
Composición que comprende gotas de aceite
|
|
WO2010138439A1
(en)
|
2009-05-28 |
2010-12-02 |
Aptapharma, Inc. |
Multiparticulate controlled-release selective serotonin reuptake inhibitor formulations
|
|
CN201441672U
(zh)
|
2009-07-14 |
2010-04-28 |
赵伟华 |
一次性灌肠装置
|
|
CN102573802A
(zh)
|
2009-08-12 |
2012-07-11 |
希格默伊德药业有限公司 |
包含聚合物基质和油相的免疫调节组合物
|
|
US20110045222A1
(en)
|
2009-08-19 |
2011-02-24 |
Eastman Chemical Company |
Oxygen-scavenging polymer blends suitable for use in packaging
|
|
GB0916335D0
(en)
|
2009-09-17 |
2009-10-28 |
Martin W J |
Medicaments
|
|
US8852631B2
(en)
|
2009-09-24 |
2014-10-07 |
Capsugel Belgium Nv |
Acid resistant capsules
|
|
US20110081320A1
(en)
|
2009-10-06 |
2011-04-07 |
Nubiome, Inc. |
Treatment/Cure of Autoimmune Disease
|
|
JP2013507394A
(ja)
|
2009-10-09 |
2013-03-04 |
プロセラ インコーポレイテッド |
自閉症スペクトル障害と診断されたヒトにおいて自閉症スペクトル障害に関連する少なくとも一つの症状を低減するための、ペディオコッカス属を含む組成物及び方法
|
|
WO2011046616A2
(en)
|
2009-10-15 |
2011-04-21 |
New York University |
Methods for modulating bacterial infection
|
|
ES2610829T3
(es)
|
2009-11-11 |
2017-05-03 |
Alimentary Health Limited |
Cepa de Bifidobacterium
|
|
EA201290317A1
(ru)
|
2009-11-13 |
2012-10-30 |
Кэпсьюджел Белджиум Нв |
Способ контроля герметичных капсул с использованием процесса определения качества герметичности, а также соответствующее оборудование для контроля на производственной линии
|
|
LT2523661T
(lt)
|
2010-01-15 |
2017-08-10 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Nkcc inhibitoriai autizmo gydymui
|
|
US20110218216A1
(en)
|
2010-01-29 |
2011-09-08 |
Kumaravel Vivek |
Extended release pharmaceutical composition of donepezil
|
|
US7888062B1
(en)
|
2010-02-01 |
2011-02-15 |
Microbios, Inc. |
Process and composition for the manufacture of a microbial-based product
|
|
DK3564357T3
(da)
|
2010-02-01 |
2022-06-20 |
Rebiotix Inc |
Bakterieterapi mod clostridium difficile colitis
|
|
US8853269B2
(en)
|
2010-02-04 |
2014-10-07 |
Copperhead Chemical Company Inc. |
Composition and method for treating infections and promoting intestinal health
|
|
CA2792647A1
(en)
|
2010-03-10 |
2011-09-15 |
Nogra Pharma Limited |
Compositions for colon lavage and methods of making and using same
|
|
US9707207B2
(en)
|
2010-05-26 |
2017-07-18 |
The United States Of America As Represented By The Department Of Veterans Affairs |
Method for diagnosing, preventing, and treating neurological diseases
|
|
WO2011151941A1
(ja)
|
2010-06-04 |
2011-12-08 |
国立大学法人東京大学 |
制御性ｔ細胞の増殖または集積を誘導する作用を有する組成物
|
|
WO2012013861A2
(en)
|
2010-07-26 |
2012-02-02 |
Suomen Punainen Risti Veripalvelu |
Use of blood group status iii
|
|
US20120020941A1
(en)
|
2010-07-26 |
2012-01-26 |
Suomen Punainen Risti Veripalvelu |
Use of blood group status iii
|
|
EP3424515A3
(en)
|
2010-08-04 |
2019-06-19 |
Thomas Julius Borody |
Stool collection devices and methods for using them
|
|
EP2646567A4
(en)
|
2010-10-04 |
2014-03-26 |
British Columbia Cancer Agency |
DETECTION OF FUSOBACTERIUM IN A GASTROINTESTINAL SAMPLE FOR THE DIAGNOSIS OF GASTROINTESTINAL CARCINOMA
|
|
CA2813606C
(en)
|
2010-10-07 |
2019-01-22 |
Sarkis K. Mazmanian |
Probiotic therapies for autism
|
|
ES2556960T3
(es)
|
2010-10-08 |
2016-01-21 |
Capsugel Belgium Nv |
Aparato y método para adquirir una imagen bidimensional de la superficie de un objeto tridimensional
|
|
GB201020032D0
(en)
|
2010-11-25 |
2011-01-12 |
Sigmoid Pharma Ltd |
Composition
|
|
JP5860480B2
(ja)
|
2011-01-11 |
2016-02-16 |
キャプシュゲル・ベルジウム・エヌ・ヴィ |
プルランを含む新しい硬カプセル
|
|
WO2012122274A1
(en)
|
2011-03-08 |
2012-09-13 |
Zalicus Pharmaceuticals Ltd. |
Self-emulsifying formulations and methods of use thereof
|
|
US9968638B2
(en)
|
2011-03-09 |
2018-05-15 |
Regents Of The University Of Minnesota |
Compositions and methods for transplantation of colon microbiota
|
|
WO2014152484A1
(en)
|
2013-03-14 |
2014-09-25 |
Regents Of The University Of Minnesota |
Freeze dried fecal microbiota for use in fecal microbial transplantation
|
|
US20150374761A1
(en)
|
2011-03-09 |
2015-12-31 |
Regents Of The University Of Minnesota |
Freeze dried fecal microbiota for use in fecal microbial transplantation
|
|
WO2012142605A1
(en)
|
2011-04-15 |
2012-10-18 |
Samaritan Health Services |
Rapid recolonization deployment agent
|
|
WO2013038271A1
(en)
|
2011-09-14 |
2013-03-21 |
Capsugel Belgium Nv |
Fill formulations and capsules and method of use to avoid migration of fill into or through the shell
|
|
US20140363397A1
(en)
|
2011-09-14 |
2014-12-11 |
Queen's University At Kingston |
Method for treatment of disorders of the gastrointestinal system
|
|
CN103857402A
(zh)
|
2011-10-11 |
2014-06-11 |
阿基姆医药公司 |
包括厌氧培养的人类肠道微生物群的组合物
|
|
GB201118232D0
(en)
|
2011-10-21 |
2011-12-07 |
M W Encap Ltd |
Pharmaceutical composition
|
|
ES2993669T3
(en)
|
2011-12-01 |
2025-01-03 |
Univ Tokyo |
Human-derived bacteria that induce proliferation or accumulation of regulatory t cells
|
|
US9176026B2
(en)
|
2011-12-15 |
2015-11-03 |
Pureflora, Inc. |
Device for the collection, refinement, and administration of gastrointestinal microflora
|
|
CA2872149C
(en)
|
2012-05-02 |
2019-03-19 |
Charles River Laboratories, Inc. |
Viability staining method
|
|
EP3446713A3
(en)
|
2012-05-02 |
2019-05-15 |
Capsugel Belgium NV |
Aqueous dispersions of controlled release polymers and shells and capsules thereof
|
|
US9719144B2
(en)
|
2012-05-25 |
2017-08-01 |
Arizona Board Of Regents |
Microbiome markers and therapies for autism spectrum disorders
|
|
WO2013181694A1
(en)
*
|
2012-06-04 |
2013-12-12 |
Gaurav Agrawal |
Compositions and methods for treating crohn's disease and related conditions and infections
|
|
CN102743420A
(zh)
|
2012-06-06 |
2012-10-24 |
上海交通大学 |
改善肠道菌群结构的方法及应用
|
|
GB201212010D0
(en)
|
2012-07-05 |
2012-08-22 |
Sigmoid Pharma Ltd |
Formulations
|
|
WO2014036182A2
(en)
|
2012-08-29 |
2014-03-06 |
California Institute Of Technology |
Diagnosis and treatment of autism spectrum disorder
|
|
BR112015009975A2
(pt)
|
2012-11-01 |
2017-07-11 |
Academisch Ziekenhuis Groningen |
métodos e composições para a estimulação das bactérias benéficas no trato gastrointestinal
|
|
US8906668B2
(en)
|
2012-11-23 |
2014-12-09 |
Seres Health, Inc. |
Synergistic bacterial compositions and methods of production and use thereof
|
|
EP2922555A4
(en)
|
2012-11-26 |
2016-06-15 |
Borody Thomas J |
COMPOSITIONS FOR THE RESTORATION OF A FÄKALBIOZÖNOSE AND METHOD FOR THE PRODUCTION AND USE THEREOF
|
|
JP2016509003A
(ja)
|
2013-02-04 |
2016-03-24 |
セレス セラピューティクス インコーポレイテッド |
組成物および方法
|
|
US10973861B2
(en)
*
|
2013-02-04 |
2021-04-13 |
Seres Therapeutics, Inc. |
Compositions and methods
|
|
GB201304662D0
(en)
|
2013-03-14 |
2013-05-01 |
Sigmoid Pharma Ltd |
Compositions
|
|
AU2014239883B2
(en)
|
2013-03-14 |
2019-01-17 |
Therabiome, Llc |
Targeted gastrointestinal tract delivery of probiotic organisms and/or therapeutic agents
|
|
EP2971148A4
(en)
*
|
2013-03-14 |
2016-08-17 |
Seres Therapeutics Inc |
METHODS OF DETECTING PATHOGENS AND ENRICHING FROM MATERIALS AND COMPOSITIONS
|
|
WO2014145958A2
(en)
|
2013-03-15 |
2014-09-18 |
Seres Health, Inc. |
Network-based microbial compositions and methods
|
|
WO2014176632A1
(en)
|
2013-04-30 |
2014-11-06 |
Borody Thomas J |
Compositions and methods for treating microbiota-related psychotropic conditions and diseases
|
|
US9511099B2
(en)
|
2013-06-05 |
2016-12-06 |
Rebiotix, Inc. |
Microbiota restoration therapy (MRT), compositions and methods of manufacture
|
|
US9511100B2
(en)
|
2013-06-05 |
2016-12-06 |
Rebiotix, Inc. |
Microbiota restoration therapy (MRT), compositions and methods of manufacture
|
|
KR102099503B1
(ko)
|
2013-06-05 |
2020-04-09 |
리바이오틱스, 인코퍼레이티드 |
미생물상 복원 요법(mrt) 조성물
|
|
US9782445B2
(en)
|
2013-06-05 |
2017-10-10 |
Rebiotix, Inc. |
Microbiota restoration therapy (MRT), compositions and methods of manufacture
|
|
WO2015006355A2
(en)
|
2013-07-09 |
2015-01-15 |
Puretech Ventures, Llc |
Compositions containing combinations of bioactive molecules derived from microbiota for treatment of disease
|
|
CA2926466C
(en)
|
2013-10-03 |
2021-11-16 |
Frederic Bushman |
Compositions comprising a defined microbiome and methods of use thereof
|
|
US10058576B2
(en)
|
2013-10-03 |
2018-08-28 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods comprising a defined microbiome and methods of use thereof
|
|
CN105979952B
(zh)
*
|
2013-11-25 |
2022-04-08 |
赛里斯治疗公司 |
协同细菌组合物以及其制造方法和用途
|
|
US9956282B2
(en)
|
2013-12-16 |
2018-05-01 |
Seres Therapeutics, Inc. |
Bacterial compositions and methods of use thereof for treatment of immune system disorders
|
|
EP3107553B1
(en)
|
2014-02-18 |
2021-12-01 |
Universitätsklinikum Jena |
Methods and compositions for intestinal microenvironment transfer
|
|
JP6357222B2
(ja)
|
2014-03-28 |
2018-07-11 |
株式会社ヤクルト本社 |
酪酸産生菌及びその利用
|
|
US9176113B1
(en)
|
2014-04-11 |
2015-11-03 |
Synapdx Corporation |
Methods and systems for determining autism spectrum disorder risk
|
|
US20150294081A1
(en)
|
2014-04-11 |
2015-10-15 |
Synapdx Corporation |
Methods and systems for determining autism spectrum disorder risk
|
|
GB201407822D0
(en)
|
2014-05-02 |
2014-06-18 |
Atlantic Pharmaceuticals Holdings Ltd |
Use of a composition
|
|
MA41020A
(fr)
|
2014-11-25 |
2017-10-03 |
Evelo Biosciences Inc |
Compositions probiotiques et prébiotiques, et leurs procédés d'utilisation pour la modulation du microbiome
|
|
SE1550189A1
(en)
|
2015-02-19 |
2016-08-20 |
Achim Biotherapeutics Ab |
Therapeutic and prophylactic composition produced by microbiota
|
|
BR112017024264B1
(pt)
|
2015-05-14 |
2022-07-12 |
Crestovo Holdings Llc |
Composições para transplante de flora fecal e métodos de preparação e utilização das mesmas, e dispositivos para sua administração
|
|
KR102534545B1
(ko)
|
2015-05-22 |
2023-05-18 |
아리조나 보드 오브 리젠츠 온 비하프 오브 아리조나 스테이트 유니버시티 |
자폐 스펙트럼 장애 및 관련된 증상을 치료하는 방법
|
|
MX2018005107A
(es)
|
2015-10-26 |
2018-08-09 |
Crestovo Holdings Llc |
Composiciones y metodos para la terapia relacionada con la microbiota fecal.
|
|
PL3380108T3
(pl)
|
2015-11-24 |
2023-03-27 |
Seres Therapeutics, Inc. |
Zaprojektowane kompozycje bakteryjne
|
|
EP3639834B1
(en)
|
2016-02-04 |
2023-07-12 |
Universiteit Gent |
Use of microbial communities for human and animal health
|
|
CN115887508A
(zh)
|
2016-03-04 |
2023-04-04 |
加利福尼亚大学董事会 |
微生物聚生体及其用途
|
|
EP3429604A1
(en)
|
2016-03-14 |
2019-01-23 |
Holobiome, Inc. |
Modulation of the gut microbiome to treat mental disorders or diseases of the central nervous system
|
|
WO2017210428A1
(en)
|
2016-06-01 |
2017-12-07 |
Crestovo Llc |
Compositions and methods for treating inflammatory bowel diseases (ibds) and other disorders
|
|
US10849936B2
(en)
|
2016-07-01 |
2020-12-01 |
Regents Of The University Of Minnesota |
Compositions and methods for C. difficile treatment
|
|
US20180000872A1
(en)
|
2016-07-01 |
2018-01-04 |
Regents Of The University Of Minnesota |
Compositions and methods for c. difficile treatment
|
|
US20180036352A1
(en)
|
2016-08-03 |
2018-02-08 |
Crestovo Holdings Llc |
Methods for treating ulcerative colitis
|
|
US20200016256A1
(en)
|
2016-09-22 |
2020-01-16 |
The University Of Chicago |
Immune response modulation using live biotherapeutics, for conditions such as allergy desensitization
|
|
US10092601B2
(en)
|
2016-10-11 |
2018-10-09 |
Crestovo Holdings Llc |
Compositions and methods for treating multiple sclerosis and related disorders
|
|
WO2018075886A1
(en)
|
2016-10-21 |
2018-04-26 |
The University Of Chicago |
Compositions and methods for inducing immune system maintenance to prevent and/or treat infections
|
|
EP3606325B1
(en)
|
2017-04-03 |
2024-09-04 |
Gusto Global, LLC |
Rational design of microbial-based biotherapeutics
|
|
EP3606541A1
(en)
|
2017-04-05 |
2020-02-12 |
Crestovo Holdings LLC |
Compositions and methods for treating parkinson's disease (pd) and related disorders
|
|
AU2018313765A1
(en)
|
2017-08-07 |
2020-02-27 |
Finch Therapeutics, Inc. |
Compositions and methods for decolonizing antibotic-resistant bacteria in the gut
|
|
JP2020530494A
(ja)
|
2017-08-07 |
2020-10-22 |
フィンチ セラピューティクス、インコーポレイテッド． |
健康な腸バリアを維持及び回復するための組成物及び方法
|
|
WO2019032575A1
(en)
|
2017-08-07 |
2019-02-14 |
Finch Therapeutics, Inc. |
TREATMENT OF LIVER DISEASE BY MODULATION OF MICROBIOMA
|
|
WO2019041141A1
(zh)
|
2017-08-29 |
2019-03-07 |
深圳华大基因研究院 |
解纤维素拟杆菌在制备预防和/或治疗脂质代谢相关疾病制剂中的应用
|
|
EP3678693A1
(en)
*
|
2017-09-08 |
2020-07-15 |
Evelo Biosciences, Inc. |
Bacterial extracellular vesicles
|
|
WO2019075344A1
(en)
|
2017-10-12 |
2019-04-18 |
Crestovo Holdings Llc |
FECAL MICROBIOTE TRANSPLANTATION TO TREAT HEMORRHAGIC RECTOCOLITE
|
|
KR20200125637A
(ko)
|
2018-02-23 |
2020-11-04 |
크레스토보 홀딩스 엘엘씨 |
마이크로바이옴 관련 면역요법
|
|
US20190358274A1
(en)
|
2018-05-25 |
2019-11-28 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Methods for treating autism spectrum disorder and associated symptoms
|
|
EP3999084A4
(en)
*
|
2019-07-19 |
2023-07-12 |
Finch Therapeutics Holdings LLC |
METHODS AND PRODUCTS FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS
|